Thermodynamic stability of wild-type and mutant p53 core domain
- PMID: 9405613
- PMCID: PMC24967
- DOI: 10.1073/pnas.94.26.14338
Thermodynamic stability of wild-type and mutant p53 core domain
Abstract
Some 50% of human cancers are associated with mutations in the core domain of the tumor suppressor p53. Many mutations are thought just to destabilize the protein. To assess this and the possibility of rescue, we have set up a system to analyze the stability of the core domain and its mutants. The use of differential scanning calorimetry or spectroscopy to measure its melting temperature leads to irreversible denaturation and aggregation and so is useful as only a qualitative guide to stability. There are excellent two-state denaturation curves on the addition of urea that may be analyzed quantitatively. One Zn2+ ion remains tightly bound in the holo-form of p53 throughout the denaturation curve. The stability of wild type is 6.0 kcal (1 kcal = 4.18 kJ)/mol at 25 degrees C and 9.8 kcal/mol at 10 degrees C. The oncogenic mutants R175H, C242S, R248Q, R249S, and R273H are destabilized by 3.0, 2.9, 1.9, 1.9, and 0.4 kcal/mol, respectively. Under certain denaturing conditions, the wild-type domain forms an aggregate that is relatively highly fluorescent at 340 nm on excitation at 280 nm. The destabilized mutants give this fluorescence under milder denaturation conditions.
Figures





Similar articles
-
Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.Oncogene. 2000 Mar 2;19(10):1245-56. doi: 10.1038/sj.onc.1203434. Oncogene. 2000. PMID: 10713666
-
Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue.Acta Crystallogr D Biol Crystallogr. 2013 Oct;69(Pt 10):2146-56. doi: 10.1107/S0907444913020830. Epub 2013 Sep 20. Acta Crystallogr D Biol Crystallogr. 2013. PMID: 24100332 Free PMC article.
-
Conversion of wild-type p53 core domain into a conformation that mimics a hot-spot mutant.J Mol Biol. 2003 Oct 17;333(2):443-51. doi: 10.1016/j.jmb.2003.08.026. J Mol Biol. 2003. PMID: 14529628
-
Enhancement of oligomeric stability by covalent linkage and its application to the human p53tet domain: thermodynamics and biological implications.Biochem Soc Trans. 2007 Dec;35(Pt 6):1574-8. doi: 10.1042/BST0351574. Biochem Soc Trans. 2007. PMID: 18031269 Review.
-
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.Cancer Res. 2000 Dec 15;60(24):6788-93. Cancer Res. 2000. PMID: 11156366 Review.
Cited by
-
Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations.Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221139262. doi: 10.1177/03946320221139262. Int J Immunopathol Pharmacol. 2022. PMID: 36377597 Free PMC article.
-
REACTIN: regulatory activity inference of transcription factors underlying human diseases with application to breast cancer.BMC Genomics. 2013 Jul 26;14:504. doi: 10.1186/1471-2164-14-504. BMC Genomics. 2013. PMID: 23885756 Free PMC article.
-
Wrapping effects within a proposed function-rescue strategy for the Y220C oncogenic mutation of protein p53.PLoS One. 2013;8(1):e55123. doi: 10.1371/journal.pone.0055123. Epub 2013 Jan 24. PLoS One. 2013. PMID: 23365691 Free PMC article.
-
G-actin guides p53 nuclear transport: potential contribution of monomeric actin in altered localization of mutant p53.Sci Rep. 2016 Sep 7;6:32626. doi: 10.1038/srep32626. Sci Rep. 2016. PMID: 27601274 Free PMC article.
-
Structural and functional implications of p53 missense cancer mutations.PMC Biophys. 2009 Jun 26;2(1):5. doi: 10.1186/1757-5036-2-5. PMC Biophys. 2009. PMID: 19558684 Free PMC article.
References
-
- Lane D P. Nature (London) 1992;358:15–16. - PubMed
-
- Kastan M B, Onyekwere O, Sidransky D, Vogelstein B, Craig R W. Cancer Res. 1991;51:6304–6311. - PubMed
-
- Polyak K, Xia Y, Zweier J L, Kinzler K W, Vogelstein B. Nature (London) 1997;389:300–305. - PubMed
-
- Ciechanover A, Shkedy D, Oren M, Bercovich B. J Biol Chem. 1994;269:9582–9589. - PubMed
-
- Haupt Y, Maya R, Kazaz A, Oren M. Nature (London) 1997;387:296–299. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous